이명의 복합 약물치료 효과 비교 = Comparison of the Efficacy of Combined Medical Therapy for Tinnitus

다국어 초록 (Multilingual Abstract)

Little is known about the mechanism that causes tinnitus and there is no definite treatment. In practice, a combination of drugs is preferred over a single drug regimen. The aim of this study is to evaluate and compare the effectiveness of 3 kinds of combination regimen for tinnitus. Subjects and Methods：We reviewed the records of 128 patients (156 ears) with tinnitus. Fifty of these patients were treated with ginkgo biloba extract, anti-platelet and anxiolytics. Another 50 patients were treated with ginkgo biloba extract, anxiolytics and vasodilator. Twenty-eight patients were treated with anxiolytics and vasodilator. Pre and post-treatment of 2-3 month statuses were analyzed by tinnitus handicap inventory (THI), visual analog scale (VAS) and Beck depression inventory (BDI). Results：Subjective tinnitus was improved in all three groups with no significant difference in tinnitus handicap inventory scores between the three observed groups. There was no difference between the response group and the non-response group in age, sex and tinnitus characteristics. The response group had a tendency to have lower BDI and normal hearing level compared to the non-response group. Conclusion：Patients with lower BDI and normal hearing level have a tendency to improve tinnitus after combined medical therapy, though there were no significant differences according to treatment regimens.

국문 초록 (Abstract)

복합약물 처방의 조합에 따른 치료 효과는 유의한 차이를 보이지 않았지만, 우울증이나 다른 기저 질환 및난청이 동반되지 않은 주관적 이명 환자에서 그 치료효과를 더 기대해 볼 수 있을 것으로 사료된다.

참고문헌 (Reference)

1 정연훈, "이명에 대한 Glutamate 길항제의 치료효과" 대한이비인후과학회 46 (46): 935-939, 2003

2 Johnson RM, "Use of alprazolam for relief of tinnitus. A double-blind study" 119 (119): 842-845, 1993

3 Malouff JM, "Tinnitus-related Distress: a review of recent findings" 13 (13): 31-36, 2011

4 Bartels H, "Tinnitus and neural plasticity of the brain" 28 (28): 178-184, 2007

5 Plath P, "Results of combined low-power laser therapy and extracts of ginkgo biloba in cases of sensorineural hearing loss and tinnitus" 49 : 101-104, 1995

6 Newman CW, "Psychometric adequacy of the tinnitus handicap inventory (THI) for evaluating treatment outcome" 9 (9): 153-160, 1998

7 Park CW, "Pharmacologic treatment for tinnitus" 14 (14): 1-7, 2010

8 Park CW, "Pharmacologic therapy for tinnitus. Tinnitus basics and clinical management" 49-60, 1999

9 Jastreboff PJ, "Phantom auditory perception (tinnitus): mechanisms of generation" 8 (8): 221-254, 1990

10 Mangabeira-Albernaz PL, "Metabolic aspects of labyrinthine disease-A progress report, In Vertigo, Nausea, Tinnitus and Hypoacusia in Metabolic Disorders" Elsevier Science 135-138, 1998

11 Shulman A, "Medical methods, drug therapy and tinnitus control strategies, In Tinnitus: diagnosis/ treatment. 2nd ed" Lea & Febiger 453-489, 1997

12 Kleijnen J, "Ginkgo biloba" 340 (340): 1136-1139, 1992

13 Coles RR, "Epidemiology of tinnitus: (1) prevalence" 98 : 7-15, 1984

14 Rosen S, "Diery prevention of hearing loss" 70 (70): 242-247, 1970

15 Chon KM, "Diagnosis and treatment of tinnitus" 7 (7): 326-339, 1996

16 Newman CW, "Development of the tinnitus handicap inventory" 122 (122): 143-148, 1996

17 Lechtenberg R, "Benzodiazepines in the treatment of tinnitus" 98 (98): S271-S276, 1984

18 Lee MH, "An effect of ginkgo extract on salicylate ototoxicity in guinea pigs" 40 (40): 970-975, 1997

19 Dobie RA, "A review of randomized clinical trials in tinnitus" 109 (109): 1202-1211, 1999

20 Han JM, "A clinical study of depressive trends in medically ill patients with the beck depression inventory" 24 (24): 487-502, 1986